Company News: Page (1) of 1 - 02/14/18 Email this story to a friend. email article Print this page (Article printing at page facebook

Mallinckrodt Enrolls First Patient in Phase 1 Study of ExpressGraft™C9T1 Skin Tissue

-- Study of Genetically Engineered Human Skin Substitute to Assess Safety and Tolerability in the Treatment of Diabetic Foot Ulcers -- (February 14, 2018)
This article is no longer available,but here are some related topics.

Page: 1

Related Keywords:Pro AV,Management,Presentors,Business,Law,Business Issues,Presentation,Channel/Distribution,People,Events,USA,Medicine,Pregnancy,Surgery,Medication,Pregnancy,Science,Medical,Chemistry,Business,Other,


Our Privacy Policy --- @ Copyright, 2015 Digital Media Online, All Rights Reserved